Document is current
Any future updates will be listed below
-
Authors
Hiller, Louise
Dunn, Janet A.
Loi, Shrushma
Vallier, Anne-Laure
Howe, Donna L.
Cameron, David A.
Miles, David
Wardley, Andrew M.
Earl, Helena M.
-
Funding
Funding for this research was provided by:
Health Technology Assessment Programme (06/303/98)
University Hosptials Coventry and Warwickshire NHS Trust (Research Capability Funding)
- License Information
-
More Information
Article History
Received: 9 August 2017
Accepted: 26 March 2018
First Online: 5 April 2018
Ethics approval and consent to participate
: The Persephone trial was approved by North West Multi-Research Ethics Committee (07/MRE08/35) on 9th August 2007, is conducted in accordance with the declaration of Helsinki and supported by the NCRN (No 4078). Permissions to conduct the trial at each site were obtained from individual NHS Trusts. All sites were activated between 16-Oct-07-12-Mar-15. Implied consent for this survey was obtained by participation of the individual clinicians at each site.
: Not applicable
: DC reports grant and consultancy fees from Roche. AW received advisory and speaker fees from Roche, outside the submitted work. HME received funding from Roche for trial coordination for another trial, and free drug from Roche for another trial. All remaining authors have declared no conflicts of interest [LH, JAD, SL, ALV, DLH, DM].
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
